Cargando…
Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
Sirolimus is a hydrophobic macrolide compound that has been used for long-term immunosuppressive therapy, prevention of restenosis, and treatment of lymphangioleiomyomatosis. In this study, a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated f...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829871/ https://www.ncbi.nlm.nih.gov/pubmed/33467464 http://dx.doi.org/10.3390/molecules26020425 |
_version_ | 1783641271165779968 |
---|---|
author | Nguyen, Thi-Thao-Linh Duong, Van-An Vo, Dang-Khoa Jo, Jeongae Maeng, Han-Joo |
author_facet | Nguyen, Thi-Thao-Linh Duong, Van-An Vo, Dang-Khoa Jo, Jeongae Maeng, Han-Joo |
author_sort | Nguyen, Thi-Thao-Linh |
collection | PubMed |
description | Sirolimus is a hydrophobic macrolide compound that has been used for long-term immunosuppressive therapy, prevention of restenosis, and treatment of lymphangioleiomyomatosis. In this study, a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated for the simultaneous determination of sirolimus in both porcine whole blood and lung tissue. Blood and lung tissue homogenates were deproteinized with acetonitrile and injected into the LC-MS/MS system for analysis using the positive electrospray ionization mode. The drug was separated on a C18 reversed phase column with a gradient mobile phase (ammonium formate buffer (5 mM) with 0.1% formic acid and acetonitrile) at 0.2 mL/min. The selected reaction monitoring transitions of m/z 931.5 → 864.4 and m/z 809.5 → 756.5 were applied for sirolimus and ascomycin (the internal standard, IS), respectively. The method was selective and linear over a concentration range of 0.5–50 ng/mL. The method was validated for sensitivity, accuracy, precision, extraction recovery, matrix effect, and stability in porcine whole blood and lung tissue homogenates, and all values were within acceptable ranges. The method was applied to a pharmacokinetic study to quantitate sirolimus levels in porcine blood and its distribution in lung tissue following the application of stents in the porcine coronary arteries. It enabled the quantification of sirolimus concentration until 2 and 14 days in blood and in lung tissue, respectively. This method would be appropriate for both routine porcine pharmacokinetic and bio-distribution studies of sirolimus formulations. |
format | Online Article Text |
id | pubmed-7829871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78298712021-01-26 Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents Nguyen, Thi-Thao-Linh Duong, Van-An Vo, Dang-Khoa Jo, Jeongae Maeng, Han-Joo Molecules Article Sirolimus is a hydrophobic macrolide compound that has been used for long-term immunosuppressive therapy, prevention of restenosis, and treatment of lymphangioleiomyomatosis. In this study, a simple and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed and validated for the simultaneous determination of sirolimus in both porcine whole blood and lung tissue. Blood and lung tissue homogenates were deproteinized with acetonitrile and injected into the LC-MS/MS system for analysis using the positive electrospray ionization mode. The drug was separated on a C18 reversed phase column with a gradient mobile phase (ammonium formate buffer (5 mM) with 0.1% formic acid and acetonitrile) at 0.2 mL/min. The selected reaction monitoring transitions of m/z 931.5 → 864.4 and m/z 809.5 → 756.5 were applied for sirolimus and ascomycin (the internal standard, IS), respectively. The method was selective and linear over a concentration range of 0.5–50 ng/mL. The method was validated for sensitivity, accuracy, precision, extraction recovery, matrix effect, and stability in porcine whole blood and lung tissue homogenates, and all values were within acceptable ranges. The method was applied to a pharmacokinetic study to quantitate sirolimus levels in porcine blood and its distribution in lung tissue following the application of stents in the porcine coronary arteries. It enabled the quantification of sirolimus concentration until 2 and 14 days in blood and in lung tissue, respectively. This method would be appropriate for both routine porcine pharmacokinetic and bio-distribution studies of sirolimus formulations. MDPI 2021-01-15 /pmc/articles/PMC7829871/ /pubmed/33467464 http://dx.doi.org/10.3390/molecules26020425 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nguyen, Thi-Thao-Linh Duong, Van-An Vo, Dang-Khoa Jo, Jeongae Maeng, Han-Joo Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents |
title | Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents |
title_full | Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents |
title_fullStr | Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents |
title_full_unstemmed | Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents |
title_short | Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents |
title_sort | development and validation of a bioanalytical lc-ms/ms method for simultaneous determination of sirolimus in porcine whole blood and lung tissue and pharmacokinetic application with coronary stents |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829871/ https://www.ncbi.nlm.nih.gov/pubmed/33467464 http://dx.doi.org/10.3390/molecules26020425 |
work_keys_str_mv | AT nguyenthithaolinh developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents AT duongvanan developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents AT vodangkhoa developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents AT jojeongae developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents AT maenghanjoo developmentandvalidationofabioanalyticallcmsmsmethodforsimultaneousdeterminationofsirolimusinporcinewholebloodandlungtissueandpharmacokineticapplicationwithcoronarystents |